 |
The Journal of Neuroscience, July 9, 2003, 23(14):6058-6062
Previous Article | Next Article 
BRIEF COMMUNICATION
Possible Involvement of P2Y2 Metabotropic Receptors in ATP-Induced Transient Receptor Potential Vanilloid Receptor 1-Mediated Thermal Hypersensitivity
Tomoko Moriyama,1
Tohko Iida,1,2
Kimiko Kobayashi,3
Tomohiro Higashi,1
Tetsuo Fukuoka,3
Hideki Tsumura,4
Catherine Leon,5
Noboru Suzuki,4
Kazuhide Inoue,6,7
Christian Gachet,5
Koichi Noguchi,3 and
Makoto Tominaga1
1Department of Cellular and Molecular Physiology,
Mie University School of Medicine, Tsu, Mie 514-8507, Japan,
2Inoue Foundation for Science, Tokyo 150-0033, Japan,
3Department of Anatomy and Neuroscience, Hyogo College
of Medicine, Hyogo 663-8501, Japan, 4Institute of
Laboratory Animals, Mie University, Tsu, Mie 514-8507,
5Institut National de la Santé et de la
Recherche Médicale Unité 311, 67065 Strasbourg, France,
6Division of Biosignaling, National Institute of
Health Sciences, Tokyo 158-8501, and 7Department of
Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences,
Kyushu University, Fukuoka 812-8582, Japan
 |
Abstract
|
|---|
The capsaicin receptor transient receptor potential V1 (TRPV1; also known
as vanilloid receptor 1) is a sensory neuron-specific ion channel that serves
as a polymodal detector of pain-producing chemical and physical stimuli. It
has been reported that extracellular ATP potentiates the TRPV1 currents evoked
by capsaicin or protons and reduces the temperature threshold for its
activation through metabotropic P2Y receptors in a PKC-dependent pathway,
suggesting that TRPV1 activation could trigger the sensation of pain at normal
body temperature in the presence of ATP. Here, we show that ATP-induced
thermal hyperalgesia was abolished in mice lacking TRPV1, suggesting the
functional interaction between ATP and TRPV1 at a behavioral level. However,
thermal hyperalgesia was preserved in P2Y1 receptor-deficient mice.
Patch-clamp analyses using mouse dorsal root ganglion neurons indicated the
involvement of P2Y2 rather than P2Y1 receptors.
Coexpression of TRPV1 mRNA with P2Y2 mRNA, but not P2Y1
mRNA, was determined in the rat lumbar DRG using in situ
hybridization histochemistry. These data indicate the importance of
metabotropic P2Y2 receptors in nociception through TRPV1.
Key words: pain; thermal hyperalgesia; capsaicin receptor; P2Y receptor; ATP; UTP
 |
Introduction
|
|---|
The sensation of pain allows us to recognize injury and triggers
appropriate protective responses. A specific population of primary afferent
neurons called nociceptors are known to be involved in the detection of
noxious thermal, mechanical, or chemical stimuli and can be distinguished by
their sensitivity to capsaicin, the pungent ingredient in hot chili peppers
(Szallasi and Blumberg, 1999 ;
Wood and Perl, 1999 ;
Woolf and Salter, 2000 ). The
capsaicin receptor transient receptor potential V1 (TRPV1; also known as
vanilloid receptor 1), a member of the transient receptor potential ion
channel superfamily (Minke and Cook,
2002 ), is a nonspecific cation channel with six transmembrane
domains expressed predominantly in unmyelinated C fibers and activated not
only by capsaicin but also by noxious heat (>43°C) or protons
(acidification), both of which cause pain in vivo
(Caterina et al., 1997 ;
Tominaga et al., 1998 ;
Caterina and Julius, 2001 ).
Recently, TRPV1 has been reported to respond to anandamide
(Zygmunt et al., 1999 ),
lipoxygenase products (Hwang et al.,
2000 ), and N-arachidonoyl-dopamine
(Huang et al., 2002 ).
Furthermore, analyses of mice lacking TRPV1 have shown that TRPV1 is essential
for selective modalities of pain sensation and for tissue injury-induced
thermal hyperalgesia, further suggesting a critical role for TRPV1 in the
detection or modulation of pain (Caterina
et al., 2000 ; Davis et al.,
2000 ).
Tissue damage associated with infection, inflammation, or ischemia produces
an array of chemical mediators that activate or sensitize nociceptor terminals
to elicit or exacerbate pain at the site of injury in addition to the release
of the mediators from the nociceptor terminals themselves. One of the
important components of this acute proalgesic response is ATP released from
the cytosol of the damaged or ruptured cells and sensory neurons
(Sawynok and Sweeney, 1989 ;
Lazarowski et al., 2000 ;
Dunn et al., 2001 ).
Extracellular ATP excites nociceptor endings
(Cook and McCleskey, 2002 ),
evoking a sensation of pain (Sawynok and
Sweeney, 1989 ; Dunn et al.,
2001 ). In these neurons, the most widely studied targets of
extracellular ATP have been ionotropic ATP (P2X) receptors
(North and Barnard, 1997 ;
Ralevic and Burnstock, 1998 ;
Dunn et al., 2001 ). Indeed,
several P2X receptor subtypes have been identified in sensory neurons,
including one (P2X3) whose expression is primarily confined to
these cells (Chen et al., 1995 ;
Lewis et al., 1995 ). In
contrast, possible roles for metabotropic ATP (P2Y) receptors in nociceptive
signalings have received limited attention
(von Kugelgen and Wetter,
2000 ). However, there is increasing evidence that P2Y receptors
are involved in nociception (Lang et al.,
2002 ; Molliver et al.,
2002 ; Zimmermann et al.,
2002 ). Furthermore, ATP has been found recently to potentiate the
TRPV1 currents evoked by capsaicin or protons through metabotropic
P2Y1 receptor activation in a protein kinase C-dependent pathway
(Tominaga et al., 2001 ). In
the presence of extracellular ATP, the temperature threshold for TRPV1
activation was reduced from 42 to 35°C, such that normal body temperature
is capable of activating TRPV1, which might cause pain sensation. Bradykinin
has also been reported to reduce the temperature threshold for TRPV1
activation through a PKC-dependent pathway
(Sugiura et al., 2002 ). These
data suggest that phosphorylation of TRPV1 by PKC changes the agonist
sensitivity of this ion channel. Indeed, direct phosphorylation of TRPV1 by
PKC has been proven biochemically, and two serine residues as substrates for
PKC-dependent phosphorylation have been identified
(Numazaki et al., 2002 ).
Despite these findings, the involvement of metabotropic P2Y receptors in
nociception has not yet been investigated in live animals. To address this
question, we performed behavioral, electrophysiological, and histochemical
analyses to explore the expression and function of P2Y subtypes in wild-type
mice and mice lacking TRPV1. We observed a loss of ATP-induced thermal
hyperalgesia in TRPV1 knock-out mice and found that P2Y2 receptors,
but not P2Y1 receptors, could be the targets of extracellular ATP
in TRPV1-mediated thermal hyperalgesia.
 |
Materials and Methods
|
|---|
Primary cultures prepared from male adult C57BL/6 strain (wild-type) (20 gm
body weight; Japan SLC, Shizuoka, Japan) or P2Y1-deficient mice
(obtained from Dr. Gachet, Institut National de la Santé et de la
Recherche Médicale, Strasbourg, France)
(Leon et al., 1999 ) dorsal
root ganglion neurons were incubated in medium containing nerve growth factor
(100 ng/ml). Whole-cell patch-clamp recordings were performed 1 d after
preparation of DRG neurons as described previously
(Caterina et al., 1997 ).
Standard bath solution contained (in mM): 140 NaCl, 5 KCl, 2
MgCl2, 5 EGTA, 10 HEPES, and 10 glucose, pH 7.4 (adjusted with
NaOH). Pipette solution contained (in mM): 140 KCl, 5 EGTA, and 10
HEPES, pH 7.4 (adjusted with KOH). All patch-clamp experiments were performed
at room temperature.
Male C57BL/6 strain mice, P2Y1-deficient mice, or
TRPV1-deficient mice (obtained from Dr. D. Julius, University of California,
San Francisco, San Francisco, CA) were used for behavioral analyses. After 1
hr of adaptation, ATP (100 nmol), , -methylene ATP
( meATP) (20 nmol), or UTP (100 nmol) was injected intraplantarly
into one hindpaw of each mouse, and response latencies to a radiant paw
heating were measured as described previously
(Caterina et al., 2000 ). In
some experiments, mice were pretreated with
2',3'-O-(2,4,6-trinitrophenyl) (TNP)ATP (50 nmol)
or saline (control) 10 min before  meATP or UTP injection. All
procedures involving the care and use of mice and rats were performed in
accordance with Mie University and Hyogo College of Medicine institutional
guidelines and the National Institutes of Health Guide for the Care and
Use of Laboratory Animals.
Total RNA was isolated from male adult C57BL/6 strain mice and reverse
transcribed using Superscript II (Invitrogen, Gaithersburg, MD). The
gene-specific primers (5'-GTTCAATTTGGCTCTGGCCG-3' and
5'-CTGATAGGTGGCATAAACCC-3'forP2Y1;5'-CTTCAACGAGGACTTCAAGTACGTGC-3'
and 5'-CATGTTGATGGCGTTGAGGGTGTGG-3' for P2Y2) were
designed from mouse P2Y1 and P2Y2 sequences. PCR was
performed with 35 cycles of the following protocol: 94°C, 10 sec; 55°C
(for P2Y1) or 60°C (for P2Y2), 30 sec; and 68°C,
45 sec. Precise amplification of the expected fragment was confirmed by
sequencing.
For in situ hybridization, L5 DRGs of four male Sprague Dawley
rats were quickly removed and frozen in powdered dry ice. Sections (5 µm
thick) were cut with a cryostat, thaw-mounted onto Matsunami adhesive
silane-coated slides (Matsunami, Osaka, Japan), fixed in phosphate-buffered 4%
formaldehyde for 20 min, and treated with 5 µg/ml proteinase-K in 50
mM Tris-HCl and 5 mM EDTA for 3 min. The sections were
acetylated with 0.25% acetic anhydride in 0.1 M triethanolamine,
dehydrated in ascending ethanol series, and air dried. Two
35S-labeled RNA probes were prepared by in vitro
transcription of P2Y1 cDNA (GenBank accession number U22830
[GenBank]
,
nucleotides 653980) fragment and P2Y2 cDNA (GenBank
accession number L46865
[GenBank]
, nucleotides 493868) in linearized pGEM-T Easy
vector (Promega, Madison, WI) by using T7 or SP6 RNA polymerase (Promega) and
35S-UTP (PerkinElmer Life Sciences, Natick, MA), giving a specific
activity of 1.01.5 x 109 cpm/µg. A digoxigenin
(DIG)-labeled RNA antisense probe was prepared by in vitro
transcription of TRPV1 cDNA (GenBank accession number AF029310
[GenBank]
, nucleotides
149486) fragment in linearized pGEM-T Easy vector by using a DIG RNA
labeling Kit SP6/T7 (Roche Diagnostics, Mannheim, Germany). The procedures for
hybridization, washing, and visualization using DAB reaction and
autoradiography have been described previously
(Hashimoto et al., 2001 ). In
brief, sections were hybridized overnight at 55°C in humidified boxes with
each of 35S-labeled RNA probes (3 x 106 cpm) and
with a DIG-labeled probe (300 ng) in 300 µl of the hybridization buffer.
All of these sections were rinsed in 5x SSC and 5 mM DTT for
30 min at 58°C and then washed in high-stringency buffer for 30 min at
58°C. Quantification of the labeled neurons was performed using randomly
selected tissue profiles with bright-field illumination for DAB-stained
neurons or dark-field illumination for silver grains over
35S-labeled neurons (Fukuoka et
al., 2001 ). At least 200 neurons from an L5 DRG section of each of
four rats were measured.
All the chemicals were obtained from Sigma (St. Louis, MO).
 |
Results
|
|---|
To confirm the interaction between ATP and TRPV1 in the context of
ATP-induced hyperalgesia in vivo, we performed a behavioral analysis
using wild-type mice and TRPV1-deficient mice. Nociceptive responses such as
licking and biting lasted for 2 min after ATP injection in wild-type
mice. After cessation of the responses induced by intraplantar ATP injection,
mice were subjected to radiant paw heating. A significant reduction in paw
withdrawal latency was observed for 530 min after ATP injection in
wild-type mice. In contrast, TRPV1-deficient mice developed no such thermal
hypersensitivity in response to ATP injection, suggesting a functional
interaction between ATP and TRPV1 (Fig.
1A). Next, we injected  meATP to examine the
possibility that P2X receptors are involved in ATP-induced thermal
hyperalgesia (Fig.
1B). Interestingly, thermal hyperalgesia was also
observed after injection of  meATP. However, the
 meATP-induced thermal hyperalgesia appeared and disappeared more
rapidly than ATP and was blocked by TNPATP, a blocker of P2X receptors
(Tsuda et al., 1999 ).
Furthermore, we examined the effect of  meATP in TRPV1-deficient
mice. Small but significant thermal hypersensitivity was observed only 5 min
after  meATP injection (Fig.
1B), suggesting that TRPV1 does not mediate primarily
 meATP-induced thermal hyperalgesia. In addition, TNPATP
failed to inhibit the ATP-induced thermal hyperalgesia
(Fig. 1C). These
results suggest that both P2X and P2Y receptors are involved in ATP-induced
thermal hyperalgesia, although P2Y receptors seem to be involved more
predominantly and contribute to the protracted component of the ATP-induced
thermal hyperalgesia. A pharmacological analysis of ATP-induced potentiation
of TRPV1 currents evoked by capsaicin in human embryonic kidney 293 (HEK293)
cells expressing TRPV1 suggested the involvement of the P2Y1
subtype of metabotropic ATP receptors
(Tominaga et al., 2001 ).
Therefore, we extended our behavioral analyses to P2Y1-deficient
mice, which were reported to show defective platelet aggregation and increased
resistance to thrombosis (Leon et al.,
1999 ). Surprisingly, after ATP injection, mice lacking
P2Y1 exhibited a reduction in heat-evoked withdrawal latency
similar to that observed in wild-type mice, indicating that P2Y1
receptors are not involved in ATP-induced thermal hyperalgesia in mice
(Fig. 1A).
To explore the identity of the P2Y subtypes responsible for ATP-induced
thermal hyperalgesia in mice, we first examined the effects of ATP on the
capsaicin (low-dose)-evoked response in isolated mouse DRG neurons. In DRG
neurons of wild-type mice, extracellular ATP caused significant increases in
low-dose capsaicin-evoked currents, as observed in rat DRG neurons (1.07-fold
± 0.26-fold increase for controls vs 4.01-fold ± 0.92-fold
increase with ATP; p < 0.05)
(Fig. 2A,B,E)
(Tominaga et al., 2001 ). In
some of the DRG neurons examined, rapidly desensitized inward currents at -60
mV were observed after ATP application, indicative of activation of P2X
receptors (data not shown). DRG neurons without such ATP-evoked currents were
used to examine the effects of ATP on capsaicin-evoked responses to simplify
the pathway involved, although the ATP-induced potentiation of the
capsaicin-evoked responses was also observed in the cells showing ATP-evoked
inward currents (data not shown). Similar potentiation of capsaicin-evoked
currents was observed in P2Y1-deficient mice (4.37-fold ±
0.74-fold; p < 0.01 vs control)
(Fig. 2C,E),
suggesting lack of involvement of P2Y1 receptors in mouse DRG
neurons, consistent with our behavioral analyses
(Fig. 1A). We
subsequently examined the effect of another ATP-related molecule, UTP, because
this molecule is thought to be a relatively selective agonist of
P2Y2 and P2Y4 receptors
(Ralevic and Burnstock, 1998 ).
UTP potentiated the capsaicin-evoked current responses to an extent similar to
that seen for ATP (6.24-fold ± 1.59-fold; p < 0.05 vs
control) (Fig. 2D,E),
suggesting the involvement of P2Y2 or P2Y4 subtypes.
Finally, the fact that suramin, which blocks P2Y2 but not
P2Y4, abolished the potentiation by UTP (0.95-fold ±
0.57-fold; p < 0.05 vs UTP in wild type) implicates
P2Y2 as the most likely P2Y subtype involved in the potentiation of
capsaicin-evoked current responses in mouse DRG neurons.

View larger version (17K):
[in this window]
[in a new window]
|
Figure 2. Extracellular ATP or UTP potentiates capsaicin-evoked currents in DRG
neurons from wild-type or P2Y1-deficient mice. AC,
Representative traces of increases in the capsaicin (CAP)-activated currents
by extracellular ATP (100 µM) in DRG neurons from wild-type (WT)
(B) or P2Y1-deficient (C) mice. A shows
a control trace without ATP pretreatment. Holding potential was -60 mV.
D, A representative trace of increases in the capsaicin-activated
currents by UTP (100 µM) in DRG neurons from wild-type mice.
E, Effects of ATP, UTP, or UTP plus suramin (50 µM) on
the capsaicin-activated currents. Currents were normalized to the currents
initially evoked by capsaicin (100 nM) in the absence of the
additives. Normalized currents in the absence of ATP in wild-type mice, in the
presence of ATP in wild-type mice, in the presence of ATP in
P2Y1-deficient mice, in the presence of UTP in wild-type mice, or
in the presence of UTP plus suramin in wild-type mice were 1.07 ± 0.26
(n = 3), 4.01 ± 0.92 (n = 8), 4.37 ± 0.74
(n = 4), 6.24±1.58 (n = 4), or 0.95 ± 0.57
(n = 3), respectively. *p < 0.05 and
**p < 0.01 versus absence of ATP in wild type;
#p < 0.05 versus presence of UTP and suramin in wild
type; two-tailed unpaired t test. WT, Wild type.
|
|
To examine the functional importance of P2Y2 receptors, we next
investigated the expression of P2Y2 mRNA. A reverse
transcriptase-PCR study showed that P2Y2 as well as P2Y1
mRNA expression in mouse DRG neurons (Fig.
3A) was consistent with the pharmacological analyses
described above. To further support the functional relationship of P2Y
receptors with TRPV1 in the patch-clamp experiments, we examined the
coexpression of P2Y1 receptor mRNA and P2Y2 receptor
mRNA with TRPV1 mRNA in the rat lumbar DRG using in situ
hybridization histochemistry. In this experiment, 23.5 ± 4.3, 22.5
± 2.5, and 44.6 ± 5.2% of rat DRG neurons expressed
P2Y1, P2Y2, and TRPV1 mRNAs, respectively. Coexpression
of P2Y1 mRNA and TRPV1 mRNA was quite rare
(Fig. 3B). Thus, most
of the 35S-labeled P2Y1 mRNA-expressing neurons were not
stained by DAB (2.6 ± 2.0% of P2Y1 mRNA-expressing cells
were TRPV1 mRNA-positive) (Fig. 3B,
a,b, arrowheads) and vice versa (1.6 ± 1.4% of TRPV1
mRNA-expressing cells were P2Y1 mRNA-positive). However, a
significant population of DRG neurons coexpressed P2Y2 mRNA and
TRPV1 mRNA (33.6 ± 10.7% of P2Y2 mRNA-expressing cells were
TRPV1 mRNA-positive and 15.9 ± 5.2% of TRPV1 mRNA-expressing cells were
P2Y2 mRNA-positive) (Fig.
3B, c,d, arrows). These data clearly suggest that
P2Y2 receptors, but not P2Y1 receptors, can functionally
interact with TRPV1 in DRG neurons.

View larger version (97K):
[in this window]
[in a new window]
|
Figure 3. P2Y2 mRNA, but not P2Y1 mRNA, is coexpressed with
TRPV1 mRNA in DRG. A, PCR amplification of P2Y1
(a) and P2Y2 (b) cDNA fragments from the RNAs of
mouse DRG neurons. The expected sizes of the DNA fragments for mouse
P2Y1 and P2Y2 are 651 and 781 bp, respectively. N,
Negative control. B, Coexpression of TRPV1 mRNA with P2Y1
and P2Y2 mRNAs in rat DRG neurons. Double in situ
hybridization histochemistry was performed on the sections. b and
d are dark-field photomicrographs of a and c,
respectively. The TRPV1 mRNA-expressing neurons were hybridized by a
DIG-labeled antisense probe and visualized as DAB staining (brown cells in
a and c). The P2Y1 mRNA-expressing (b)
and P2Y2 mRNA-expressing (d) neurons were hybridized by
the appropriate 35S-labeled antisense probe and visualized as
clusters of silver grains. p, Positively labeled neurons. Arrowheads indicate
P2Y1 mRNA-expressing neurons that do not express TRPV1 mRNA,
whereas arrows indicate the neurons expressing both TRPV1 and P2Y2
mRNAs.
|
|
To confirm this P2Y2 receptor involvement, we examined the
effect of UTP in mice (Fig. 4).
UTP was found to cause thermal hyperalgesia with a time course similar to that
observed in ATP injection. Furthermore, TNPATP could not prevent the
UTP-induced thermal hyperalgesia, suggesting that P2Y2 receptors
are involved in ATP-induced thermal hyperalgesia in mice.
 |
Discussion
|
|---|
In this study, we demonstrate the in vivo interaction of ATP with
TRPV1. ATP could be involved in TRPV1-mediated thermal hyperalgesia through
both P2X and P2Y receptors. However, P2Y receptors seem to be involved more
predominantly, because the hyperalgesia was little affected by the P2X
receptor inhibitor TNPATP. The existence of such a mechanism between
P2Y receptors and TRPV1 is consistent with the observation that ATP-evoked
nociceptive behavior in mice is only partially reduced by disruption of the
P2X3 gene (Cockayne et al.,
2000 ; Souslova et al.,
2000 ). It has been well documented that signaling by ATP through
sensory neuron-specific P2X3 and P2X2/3 receptors
mediates an acute nociceptive pathway contributing to the pain of tissue
damage (North and Barnard,
1997 ; Ralevic and Burnstock,
1998 ; Tsuda et al.,
2000 ; Dunn et al.,
2001 ). ATP could act on both ionotropic and metabotropic receptors
to initiate and maintain the nociceptive responses in concert.
In TRPV1-transfected HEK293 cells, pharmacological studies have concluded
that P2Y1 receptors are predominantly involved in ATP-induced
potentiation or sensitization of TRPV1
(Tominaga et al., 2001 ). Our
present results indicated that P2Y2 rather than P2Y1
receptors are likely to mediate the ATP-induced potentiation of
capsaicin-evoked responses in mouse DRG neurons and in ATP-induced thermal
hypersensitivity in vivo. Consistent with this hypothesis,
P2Y2 mRNA, but not P2Y1 mRNA, is coexpressed with TRPV1
mRNA in rat DRG neurons (Fig.
3), and UTP injection causes thermal hyperalgesia in mice
(Fig. 4). Together, these data
suggest that P2Y2 receptors mediate ATP-induced hypersensitivity in
mammals. A behavioral analysis with P2Y2-deficient mice would
confirm our conclusion. P2Y2 receptor activation leads to TRPV1
potentiation in a relatively short time course. In addition, ATP and UTP have
been reported recently to cause cAMP response element-binding protein (CREB)
phosphorylation, which is likely to activate gene expression through
P2Y2 receptor activation
(Molliver et al., 2002 ).
P2Y2 receptor activation could increase intracellular
Ca2+ levels, leading to various outcomes including CREB
phosphorylation, activation of phospholipase A2, and the consequent
liberation of arachidonic acid, the rate-limiting step in prostaglandin
formation (Molliver et al.,
2002 ; Zimmermann et al.,
2002 ). This Ca2+ mobilizing process could occur more
slowly than the effects on TRPV1. Both fast and slow signals downstream of
P2Y2 receptor activation might exist in native cells and contribute
coordinately to hyperalgesia.
P2Y2 receptors confer responsiveness to UTP and ATP to a similar
extent, suggesting a possible role for UTP as an important component of
proalgesic response in the context of tissue injury. UTP has been reported to
be released from ruptured cells (Anderson
and Parkinson, 1997 ;
Lazarowski et al., 2000 ). In
addition to non-neuronal cells, ATP can be released from a subset of small
primary afferent nerves in response to capsaicin
(Sawynok and Sweeney, 1989 ),
suggesting possible autocrine and paracrine mechanisms for the exacerbation of
pain. A similar context can be imagined for the action of UTP in tissue
damage. Therefore, UTP as well as ATP should be taken into account when
purinergic contributions through P2Y receptors to pain sensation are
examined.
 |
Footnotes
|
|---|
Received Feb. 5, 2003;
revised Apr. 29, 2003;
accepted May. 2, 2003.
This work was supported by grants from the Ministry of Education, Culture,
Sports, Science and Technology of Japan, The Japan Health Sciences Foundation,
and The Sumitomo Foundation. We thank Dr. D. Julius (University of California,
San Francisco, San Francisco, CA) for supplying TRPV1-deficient mice and M. J.
Caterina (Johns Hopkins University, Baltimore, MD) for his critical reading of
this manuscript.
Correspondence should be addressed to M. Tominaga, Department of Cellular
and Molecular Physiology, Mie University School of Medicine, Tsu, Mie
514-8507, Japan. E-mail:
tominaga{at}doc.medic.mie-u.ac.jp
Copyright © 2003 Society for Neuroscience
0270-6474/03/236058-05$15.00/0
 |
References
|
|---|
Anderson CM, Parkinson FE (1997) Potential signaling
roles for UTP and UDP: sources, regulation and release of uracil nucleotides.
Trends Pharmacol Sci 18:
387392.[Medline]
Caterina MJ, Julius D (2001) The vanilloid receptor: a
molecular gateway to the pain pathway. Annu Rev Neurosci
24: 487517.[ISI][Medline]
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius
D (1997) The capsaicin receptor: a heat-activated ion channel in
the pain pathway. Nature 389:
816824.[Medline]
Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J,
Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D (2000)
Impaired nociception and pain sensation in mice lacking the capsaicin
receptor. Science 288:
306313.[Abstract/Free Full Text]
Chen CC, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G, Wood JN
(1995) A P2X purinoceptor expressed by a subset of sensory
neurons. Nature 377:
428431.[Medline]
Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S,
Malmberg AB, Cain G, Berson A, Kassotakis L, Hedley L, Lachnit WG, Burnstock
G, McMahon SB, Ford AP (2000) Urinary bladder hyporeflexia and
reduced pain-related behaviour in P2X3-deficient mice. Nature
407:
10111015.[Medline]
Cook SP, McCleskey EW (2002) Cell damage excites
nociceptors through release of cytosolic ATP. Pain
95: 4147.[ISI][Medline]
Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P,
Harries MH, Latcham J, Clapham C, Atkinson K, Hughes SA, Rance K, Grau E,
Harper AJ, Pugh PL, Rogers DC, Bingham S, Randall A, Sheardown SA
(2000) Vanilloid receptor-1 is essential for inflammatory thermal
hyperalgesia. Nature 405:
183187.[Medline]
Dunn PM, Zhong Y, Burnstock G (2001) P2X receptors in
peripheral neurons. Prog Neurobiol 65:
107134.[ISI][Medline]
Fukuoka T, Kondo E, Dai Y, Hashimoto N, Noguchi K
(2001) Brain-derived neurotrophic factor increases in the
uninjured dorsal root ganglion neurons in selective spinal nerve ligation
model. J Neurosci 21:
48914900.[Abstract/Free Full Text]
Hashimoto N, Yamanaka H, Fukuoka T, Obata K, Mashimo T, Noguchi K
(2001) Expression of hepatocyte growth factor in primary sensory
neurons of adult rats. Brain Res Mol Brain Res
97: 8388.[Medline]
Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L,
Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN,
Geppetti P, Walker JM, Di Marzo V (2002) An endogenous
capsaicin-like substance with high potency at recombinant and native vanilloid
VR1 receptors. Proc Natl Acad Sci USA
99:
84008405.[Abstract/Free Full Text]
Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, Cho S, Min KH,
Suh YG, Kim D, Oh U (2000) Direct activation of capsaicin
receptors by products of lipoxygenases: endogenous capsaicin-like substances.
Proc Natl Acad Sci USA 97:
61556160.[Abstract/Free Full Text]
Lang PM, Tracey DJ, Irnich D, Sippel W, Grafe P (2002)
Activation of adenosine and P2Y receptors by ATP in human peripheral nerve.
Naunyn Schmiedebergs Arch Pharmacol 366:
449457.[ISI][Medline]
Lazarowski ER, Boucher RC, Harden TK (2000)
Constitutive release of ATP and evidence for major contribution of
ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to
extracellular nucleotide concentrations. J Biol Chem
275:
3106131068.[Abstract/Free Full Text]
Leon C, Hechler B, Freund M, Eckly A, Vial C, Ohlmann P, Dierich A,
LeMeur M, Cazenave JP, Gachet C (1999) Defective platelet
aggregation and increased resistance to thrombosis in purinergic
P2Y1 receptor-null mice. J Clin Invest
104:
17311737.[ISI][Medline]
Lewis C, Neldhart S, Holy C, North RA, Buell G, Surprenant A
(1995) Coexpression of P2X2 and P2X3 receptor subunits can
account for ATP-gated currents in sensory neurons. Nature
377:
432435.[Medline]
Minke B, Cook B (2002) TRP channel proteins and signal
transduction. Physiol Rev 82:
429472.[Abstract/Free Full Text]
Molliver DC, Cook SP, Carlsten JA, Wright DE, McCleskey EW
(2002) ATP and UTP excite sensory neurons and induce CREB
phosphorylation through the metabotropic receptor, P2Y2. Eur J
Neurosci 16:
18501860.[ISI][Medline]
North AN, Barnard EA (1997) Nucleotide receptors.
Curr Opin Neurobiol 7:
346357.[ISI][Medline]
Numazaki M, Tominaga T, Toyooka H, Tominaga M (2002)
Direct phosphorylation of capsaicin receptor VR1 by PKC and
identification of two target serine residues. J Biol Chem
277:
1337513378.[Abstract/Free Full Text]
Ralevic V, Burnstock G (1998) Receptors for purines
and pyrimidines. Pharmacol Rev 50:
413492.[Abstract/Free Full Text]
Sawynok J, Sweeney MI (1989) The role of purines in
nociception. Neuroscience 32:
557569.[ISI][Medline]
Souslova V, Cesare P, Ding Y, Akopian AN, Stanfa L, Suzuki R,
Carpenter K, Dickenson A, Boyce S, Hill R, Nebenuis-Oosthuizen D, Smith AJ,
Kidd EJ, Wood JN (2000) Warm-coding deficits and aberrant
inflammatory pain in mice lacking P2X3 receptors. Nature
407:
10151017.[Medline]
Sugiura T, Tominaga M, Katsuya H, Mizumura K (2002)
Bradykinin lowered the threshold temperature for heat activation of vanilloid
receptor 1. J Neurophysiol 88:
544548.[Abstract/Free Full Text]
Szallasi A, Blumberg PM (1999) Vanilloid (capsaicin)
receptors and mechanisms. Pharmacol Rev
51: 159211.[Abstract/Free Full Text]
Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner
K, Raumann BE, Basbaum AI, Julius D (1998) The cloned capsaicin
receptor integrates multiple pain-producing stimuli. Neuron
21: 531543.[ISI][Medline]
Tominaga M, Wada M, Masu M (2001) Potentiation of
capsaicin receptor activity by metabotropic ATP receptors as a possible
mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci
USA 98:
69516956.[Abstract/Free Full Text]
Tsuda M, Ueno S, Inoue K (1999) In vivo
pathway of thermal hyperalgesia by intrathecal administration of
, -methylene ATP in mouse spinal cord: involvement of the
glutamate-NMDA receptor system. Br J Pharmacol
127:
449456.[ISI][Medline]
Tsuda M, Koizumi S, Kita A, Shigemoto Y, Ueno S, Inoue K
(2000) Mechanical allodynia caused by intraplantar injection of
P2X receptor agonist in rats: involvement of heteromeric P2X2/3 receptor
signaling in capsaicin-insensitive primary afferent neurons. J
Neurosci
20:RC90(15).[Abstract/Free Full Text]
von Kugelgen I, Wetter A (2000) Molecular pharmacology
of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol
362:
310323.[ISI][Medline]
Wood JN, Perl ER (1999) Pain. Curr Opin Genet
Dev 9:
328332.[ISI][Medline]
Woolf CJ, Salter MW (2000) Neuronal plasticity:
increasing the gain in pain. Science
288:
17651768.[Abstract/Free Full Text]
Zimmermann K, Reeh PW, Averbeck B (2002) ATP can
enhance the proton-induced CGRP release through P2Y receptors and secondary
PGE2 release in isolated rat dura mater. Pain
97: 259265.[ISI][Medline]
Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di
Marzo VD, Julius D, Hogestatt ED (1999) Vanilloid receptors on
sensory nerves mediate the vasodilator action of anandamide.
Nature 400:
452457.[Medline]
This article has been cited by other articles:

|
 |

|
 |
 
D. Donnelly-Roberts, S. McGaraughty, C.-C. Shieh, P. Honore, and M. F. Jarvis
Painful Purinergic Receptors
J. Pharmacol. Exp. Ther.,
February 1, 2008;
324(2):
409 - 415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhang, C.-L. Cang, Y. Kawasaki, L.-L. Liang, Y.-Q. Zhang, R.-R. Ji, and Z.-Q. Zhao
Neurokinin-1 Receptor Enhances TRPV1 Activity in Primary Sensory Neurons via PKC{varepsilon}: A Novel Pathway for Heat Hyperalgesia
J. Neurosci.,
October 31, 2007;
27(44):
12067 - 12077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Zhong and D. H. Wang
TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice
Am J Physiol Heart Circ Physiol,
September 1, 2007;
293(3):
H1791 - H1798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Lukacs, B. Thyagarajan, P. Varnai, A. Balla, T. Balla, and T. Rohacs
Dual Regulation of TRPV1 by Phosphoinositides
J. Neurosci.,
June 27, 2007;
27(26):
7070 - 7080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ren, X. Zou, L. Fang, and Q. Lin
Involvement of Peripheral Purinoceptors in Sympathetic Modulation of Capsaicin-Induced Sensitization of Primary Afferent Fibers
J Neurophysiol,
November 1, 2006;
96(5):
2207 - 2216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bielefeldt, F. Zhong, H. R. Koerber, and B. M. Davis
Phenotypic characterization of gastric sensory neurons in mice
Am J Physiol Gastrointest Liver Physiol,
November 1, 2006;
291(5):
G987 - G997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ohta, Y. Ikemi, M. Murakami, T. Imagawa, K.-i. Otsuguro, and S. Ito
Potentiation of transient receptor potential V1 functions by the activation of metabotropic 5-HT receptors in rat primary sensory neurons
J. Physiol.,
November 1, 2006;
576(3):
809 - 822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-L. Tsai, S.-Y. Chang, C.-Y. Ho, and Y. R. Kou
Neural and hydroxyl radical mechanisms underlying laryngeal airway hyperreactivity induced by laryngeal acid-pepsin insult in anesthetized rats
J Appl Physiol,
July 1, 2006;
101(1):
328 - 338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-C. Wang, W. Xiong, J. Zheng, Y. Zhou, H. Zheng, C. Zhang, L.-H. Zheng, X.-L. Zhu, Z.-Q. Xiong, L.-Y. Wang, et al.
The Timing of Endocytosis after Activation of a G-Protein-Coupled Receptor in a Sensory Neuron
Biophys. J.,
May 15, 2006;
90(10):
3590 - 3598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Albers, C. J. Woodbury, A. M. Ritter, B. M. Davis, and H. R. Koerber
Glial cell line-derived neurotrophic factor expression in skin alters the mechanical sensitivity of cutaneous nociceptors.
J. Neurosci.,
March 15, 2006;
26(11):
2981 - 2990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Burnstock
Pathophysiology and therapeutic potential of purinergic signaling.
Pharmacol. Rev.,
March 1, 2006;
58(1):
58 - 86.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Deval, V. Friend, C. Thirant, M. Salinas, M. Jodar, M. Lazdunski, and E. Lingueglia
Regulation of Sensory Neuron-specific Acid-sensing Ion Channel 3 by the Adaptor Protein Na+/H+ Exchanger Regulatory Factor-1
J. Biol. Chem.,
January 20, 2006;
281(3):
1796 - 1807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Patwardhan, K. A. Berg, A. N. Akopain, N. A. Jeske, N. Gamper, W. P. Clarke, and K. M. Hargreaves
Bradykinin-Induced Functional Competence and Trafficking of the {delta}-Opioid Receptor in Trigeminal Nociceptors
J. Neurosci.,
September 28, 2005;
25(39):
8825 - 8832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D Baker
Protein kinase C mediates up-regulation of tetrodotoxin-resistant, persistent Na+ current in rat and mouse sensory neurones
J. Physiol.,
September 15, 2005;
567(3):
851 - 867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Pitt, J. Martinez-Pinna, E. A. Barnard, and M. P. Mahaut-Smith
Potentiation of P2Y Receptors by Physiological Elevations of Extracellular K+ via a Mechanism Independent of Ca2+ Influx
Mol. Pharmacol.,
May 1, 2005;
67(5):
1705 - 1713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tominaga
Molecular Mechanisms of Trigeminal Nociception and Sensation of Pungency
Chem Senses,
January 1, 2005;
30(suppl_1):
i191 - i192.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sugiuar, K. Bielefeldt, and G. F. Gebhart
TRPV1 Function in Mouse Colon Sensory Neurons Is Enhanced by Metabotropic 5-Hydroxytryptamine Receptor Activation
J. Neurosci.,
October 27, 2004;
24(43):
9521 - 9530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Bowser and B. S. Khakh
ATP Excites Interneurons and Astrocytes to Increase Synaptic Inhibition in Neuronal Networks
J. Neurosci.,
September 29, 2004;
24(39):
8606 - 8620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-Y. Zhuang, H. Xu, D. E. Clapham, and R.-R. Ji
Phosphatidylinositol 3-Kinase Activates ERK in Primary Sensory Neurons and Mediates Inflammatory Heat Hyperalgesia through TRPV1 Sensitization
J. Neurosci.,
September 22, 2004;
24(38):
8300 - 8309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wu, G. P. Sui, and C. H. Fry
Purinergic regulation of guinea pig suburothelial myofibroblasts
J. Physiol.,
August 15, 2004;
559(1):
231 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Woodbury, M. Zwick, S. Wang, J. J. Lawson, M. J. Caterina, M. Koltzenburg, K. M. Albers, H. R. Koerber, and B. M. Davis
Nociceptors Lacking TRPV1 and TRPV2 Have Normal Heat Responses
J. Neurosci.,
July 14, 2004;
24(28):
6410 - 6415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Dai, T. Moriyama, T. Higashi, K. Togashi, K. Kobayashi, H. Yamanaka, M. Tominaga, and K. Noguchi
Proteinase-Activated Receptor 2-Mediated Potentiation of Transient Receptor Potential Vanilloid Subfamily 1 Activity Reveals a Mechanism for Proteinase-Induced Inflammatory Pain
J. Neurosci.,
May 5, 2004;
24(18):
4293 - 4299.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|